Ovelle creates ovary and egg cells from stem cells to support infertility research and treatment.
Ovelle has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
Ovelle is headquartered in Boston, United States.
Ovelle creates ovary and egg cells from stem cells to support infertility research and treatment.
Ovelle is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ovelle — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/ovelle. Accessed November 13, 2026.
VCBacked. (2026). Ovelle — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/ovelle
{{cite web |title=Ovelle — Funding & Investors |url=https://www.vcbacked.co/company/ovelle |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Ovelle? Request a listing update